Abstract
Resistance of herpes simplex virus to antiviral drugs is relatively well understood in vitro. Recent studies have related understanding gained from laboratory experiments to clinical issues, including correlations of the degree of resistance in vitro with clinical outcome, the types of resistance mutations in patient populations, and potential alternate therapies for resistant infections.

This publication has 0 references indexed in Scilit: